Status:
COMPLETED
The Efficacy of Extract of Allium Cepae, Allantoin and Heparin in Patients With Proven Scar Development
Lead Sponsor:
Suleymaniye Birth And Women's Health Education And Research Hospital
Conditions:
Cicatrix
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
To investigate the efficacy of prophylactic use of a topical gel containing extract of allium cepae, allantoin and heparin after surgical removal of the primary cesarean scar in the second cesarean se...
Detailed Description
120 patients who are admitted for the second cesarean delivery, not taking prophylactic medication after the first cesarean section, whose scar development and measurements are taken will be included ...
Eligibility Criteria
Inclusion
- Patients who are admitted for the second cesarean delivery
- Not to use topical scar gel after the first c-section
Exclusion
- chronic illness, immunosuppressive therapy or smoking
- development of wound infection during the second c- section
- allergies and hypersensitivities to components of the gel
Key Trial Info
Start Date :
December 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02708628
Start Date
December 1 2015
End Date
October 1 2016
Last Update
October 4 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Suleymaniye Birth And Women's Health Education And Research Hospital.
Istanbul, Turkey (Türkiye), 34020